Viewing Study NCT07480733


Ignite Creation Date: 2026-03-26 @ 3:19 PM
Ignite Modification Date: 2026-03-31 @ 12:39 PM
Study NCT ID: NCT07480733
Status: NOT_YET_RECRUITING
Last Update Posted: 2026-03-25
First Post: 2026-03-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase II Study of JS212/JS213 as Monotherapy and in Combination in Patients With Advanced Malignant Solid Tumors
Sponsor: Shanghai Junshi Bioscience Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module